Jianji Chen

Jianji Chen

Auto-generated profile, based on publicly available information

Jianji Chen

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA; Graduate Program in Genetics & Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2016 in Science
Verified
Journal Article
Closed access
PDF file
DFDong Fang
Dong Fang
HGHaiyun Gan
Haiyun Gan
JLJeong-Heon Lee
Jeong-Heon Lee
JHJing Han
Jing Han
ZWZhiquan Wang
Zhiquan Wang
ZZZhiguo Zhang
Zhiguo Zhang
A cancer-promoting histone protein: Mutations in the chromatin protein histone H3 are found in a number of pediatric cancers. The lysine-36–to–methionine (K36M) “oncohistone” mutation is seen in almost all chondroblastomas. Fang et al. show that the K36M mutant histones inhibit the normal methylation of this same residue in wild-type H3 histones. They do so by interfering with the enzymes that normally methylate this residue. The altered chromatin methylation patterns alter the expression of known cancer-related genes and impart cancer-related characteristics to the chondrocyte cells. Science , this issue p. 1344

1 August 2013 in Chemosphere
Verified
Journal Article
Closed access
XLXuehua Li
Xuehua Li
WZWenxing Zhao
Wenxing Zhao
JLJing Li
Jing Li
JJJingqiu Jiang
Jingqiu Jiang
JCJianji Chen
Jianji Chen
Jingwen ChenJingwen Chen
Jingwen Chen

19 February 2016 in Journal of Proteome Research
Verified
Journal Article
Closed access
TZTong Zhou
Tong Zhou
YCYing-Hua Chung
Ying-Hua Chung
JCJianji Chen
Jianji Chen
Yue ChenYue Chen
Yue Chen

1 August 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
THTewfik Hamidi
Tewfik Hamidi
ASAnup Kumar Singh
Anup Kumar Singh
NVNicolas Veland
Nicolas Veland
VVVidyasiri Vemulapalli
Vidyasiri Vemulapalli
JCJianji Chen
Jianji Chen
Taiping ChenTaiping Chen
Taiping Chen
Set7/9 (also known as Set7, Set9, Setd7, and Kmt7) is a lysine methyltransferase that catalyzes the methylation of multiple substrates, including histone H3 and non-histone proteins. Although not essential for normal development and physiology, Set7/9-mediated methylation events play important roles in regulating cellular pathways involved in various human diseases, making Set7/9 a promising therapeutic target. Multiple Set7/9 inhibitors have been developed, which exhibit varying degrees of potency and selectivity in vitro. However, validation of these compounds in vivo has been hampered by the lack of a reliable cellular biomarker for Set7/9 activity. Here, we report the identification of Rpl29, a ribosomal protein abundantly expressed in all cell types, as a major substrate of Set7/9. We show that Rpl29 lysine 5 (Rpl29K5) is methylated exclusively by Set7/9 and can be demethylated by Lsd1 (also known as Kdm1a). Rpl29 is not a core component of the ribosome translational machinery and plays a regulatory role in translation efficiency. Our results indicate that Rpl29 methylation has no effect on global protein synthesis but affects Rpl29 subcellular localization. Using an Rpl29 methylation-specific antibody, we demonstrate that Rpl29K5 methylation is present ubiquitously and validate that (R)-PFI-2, a Set7/9 inhibitor, efficiently reduces Rpl29K5 methylation in cell lines. Thus, Rpl29 methylation can serve as a specific cellular biomarker for measuring Set7/9 activity.

7 November 2019 in Genes & Development
Verified
Journal Article
Open access
PDF file
XWXiao Wu
Xiao Wu
SLShichang Liu
Shichang Liu
CSCari Sagum
Cari Sagum
JCJianji Chen
Jianji Chen
RSRajesh Singh
Rajesh Singh
BWBin Wang
Bin Wang
The establishment of polyubiquitin conjugates with distinct linkages play important roles in the DNA damage response. Much remains unknown about the regulation of linkage-specific ubiquitin signaling at sites of DNA damage. Here we reveal that Cezanne (also known as Otud7B) deubiquitinating enzyme promotes the recruitment of Rap80/BRCA1-A complex by binding to Lys63-polyubiquitin and targeting Lys11-polyubiquitin. Using a ubiquitin binding domain protein array screen, we identify that the UBA domains of Cezanne and Cezanne2 (also known as Otud7A) selectively bind to Lys63-linked polyubiquitin. Increased Lys11-linkage ubiquitination due to lack of Cezanne DUB activity compromises the recruitment of Rap80/BRCA1-A. Cezanne2 interacts with Cezanne, facilitating Cezanne in the recruitment of Rap80/BRCA1-A, Rad18, and 53BP1, in cellular resistance to ionizing radiation and DNA repair. Our work presents a model that Cezanne serves as a “reader” of the Lys63-linkage polyubiquitin at DNA damage sites and an “eraser” of the Lys11-linkage ubiquitination, indicating a crosstalk between linkage-specific ubiquitination at DNA damage sites.

1 December 2020 in Methods
Verified
Journal Article
Closed access
JCJianji Chen
Jianji Chen
CSCari Sagum
Cari Sagum
MBMark Bedford
Mark Bedford